|
Model Number REACT-71 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Hematoma (1884); Intracranial Hemorrhage (1891)
|
Event Date 02/12/2024 |
Event Type
Injury
|
Event Description
|
Medtronic received a report that the patient underwent thrombectomy on (b)(6) 2024 and computerized tomography (ct) reexamination found bleeding on (b)(6) 2024.The investigator reviewed the post-transfer chart on (b)(6) 2024 and learned the patient's bleeding was aggravated and turned into ph2.Multiple hematoma removal and debulking flap decompression were performed on (b)(6) 2024.Baseline modified rankin scale (mrs) score 0, baseline national institutes of health stroke scale (nihss) 12.The patient was transferred to neurosurgery for treatment.This event led to a surgical procedure and hospitalization.The patient is recovering and the issue is resolving.This is not a recurrent or new stroke.This adverse event (ae) is possibly related to the disease under study and possibly related to an underlying condition or disease.This event did not result from device deficiency.This event did not lead to congenital anomaly, death, or disability and was not considered life-threatening.The site assessed this event as not related to the study device or procedure.The sponsor assessed this event as possibly related to the procedure.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information received reported diagnostic imaging : head computer tomography (ct) without contrast resulting ph2 on (b)(6) 2024.
|
|
Search Alerts/Recalls
|
|
|